Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

1959 • 14,850 citations

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

1979 • 2,308 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1976 • 2,290 citations

The principles and practice of oncology

2001 • 966 citations

Statistical Methods in Medical Research

1972 • 754 citations

Phase II evaluation of adriamycin in human neoplasia

1973 • 414 citations

Dose response evaluation of adriamycin in human neoplasia

1977 • 389 citations

Surgical Treatment of 297 Soft Tissue Sarcomas of the Lower Extremity

1975 • 354 citations

The Problem of Local Recurrence after Treatment of Soft Tissue Sarcoma

1968 • 301 citations

Management of soft tissue sarcomas of the extremities

2004 • 294 citations

Adriamycin (NSC 123127) cardiomyopathy. An overview with determination of risk factors

1975 • 274 citations

Treatment of cancer and allied diseases

1940 • 223 citations

Exact and asymptotic methods for the combination of 2 × 2 tables

1975 • 175 citations

Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide Cineangiography

1981 • 172 citations

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.

1976 • 140 citations

Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas.

1978 • 133 citations

Adriamycin: A new effective agent in the therapy of disseminated sarcomas

1975 • 97 citations

Tumors of Bone and Soft Tissue

1966 • 96 citations

Management of Primary Bone and Soft Tissue Tumors

1976 • 96 citations

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).

1970 • 77 citations

Soft tissue sarcoma.A review of 200 cases

1963 • 72 citations

Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.

1975 • 71 citations

Perspectives on the role of surgery and radiation therapy in the treatment of soft tissue sarcomas of the extremities.

1981 • 63 citations

Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.

1976 • 43 citations

A Clinical Trial Adriamycin (NSC 123127) in Advanced Sarcomas

1977 • 40 citations

Soft part sarcomas revisited. Review and comparison of a second series

1972 • 34 citations

A prelusive clinical trial of cyclophosphamide.

1960 • 34 citations

Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.

1979 • 33 citations

Effect of vincristine (NSC-67574) on malignant solid tumors in children.

1968 • 29 citations

Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.

1979 • 27 citations

Chemotherapy of sarcomas-a perspective.

1981 • 22 citations

Tumors of the soft somatic tissues and bone

1964 • 20 citations

Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.

1977 • 15 citations

Low doses of vincristine (NSC-67574) for malignant disease.

1969 • 12 citations